Helping people who inject drugs with HIV by reducing stigma through quick treatment access
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention
This study is looking to help people in Malaysia who inject drugs and are living with HIV by making it easier for them to get the treatment they need without facing judgment, so they can feel supported and stick to their care plan.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11129140 on NIH RePORTER |
What this research studies
This research focuses on addressing the stigma faced by people who inject drugs (PWID) living with HIV in Malaysia, a country experiencing rising HIV rates. The project aims to implement a rapid start antiretroviral therapy intervention that encourages healthcare providers to offer treatment without discrimination. By utilizing behavioral design strategies, the research seeks to change how physicians make decisions regarding ART prescriptions, ultimately improving access to care for PWID. The study will evaluate the effectiveness of these interventions in reducing stigma and increasing treatment adherence among this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are living with HIV, particularly in Malaysia.
Not a fit: Patients who do not inject drugs or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV treatment for people who inject drugs, ultimately reducing HIV transmission rates.
How similar studies have performed: While stigma-reducing interventions have been explored, this approach using behavioral design strategies is relatively novel and has not been extensively tested in similar contexts.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Altice, Frederick Lewis — Yale University
- Study coordinator: Altice, Frederick Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.